Rapamycin Generates Graft-Homing Murine Suppressor CD8+ T Cells That Confer Donor-Specific Graft Protection

Cell Transplantation - United States
doi 10.3727/096368911x566244
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

PD-L1 Interacts With CD80 to Regulate Graft-Versus-Leukemia Activity of Donor CD8+ T Cells

Journal of Clinical Investigation
Medicine
2017English

Donor CD8+ T Cells Mediate Graft-Versus-Leukemia Activity Without Clinical Signs of Graft-Versus-Host Disease in Recipients Conditioned With Anti-Cd3 Monoclonal Antibody

Journal of Immunology
AllergyImmunology
2007English

CD103 Deficiency Prevents Graft-Versus-Host Disease but Spares Graft-Versus-Tumor Effects Mediated by Alloreactive CD8 T Cells

PLoS ONE
Multidisciplinary
2011English

Dendritic Cells Induce Antigen-Specific Regulatory T Cells That Prevent Graft Versus Host Disease and Persist in Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
2011English

Prevention of Graft Rejection by Donor Type II CD8+ T Cells (Tc2 Cells) Is Not Sufficient to Improve Engraftment in Fetal Transplantation

Fetal Diagnosis and Therapy
Nuclear MedicineRadiologyChild HealthGynecologyPerinatologyImagingObstetricsMedicinePediatricsEmbryology
2004English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2008English

Virtual Memory CD8 T Cells Expanded by Helminth Infection Confer Broad Protection Against Bacterial Infection

Mucosal Immunology
AllergyImmunology
2018English

Photoconversion of Alloreactive T Cells in Murine Peyer’s Patches During Acute Graft-Versus-Host Disease: Tracking the Homing Route of Highly Proliferative Cells in Vivo

Frontiers in Immunology
AllergyImmunology
2018English

Rapamycin Resistant Murine Th9 Cells Have a Stable in Vivo Phenotype and Inhibit Graft-Versus-Host Reactivity

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy